74
Participants
Start Date
December 31, 2012
Primary Completion Date
September 30, 2018
Study Completion Date
April 30, 2019
Everolimus
10 mg per day of everolimus during 24 months or until progression disease
embolization
2 sessions embolization with spheric particles
Doxorubicin
2 sessions chemoembolization with 10 mg of lipiodol with 100 mg of doxorubicine
CHU - Hôtel Dieu, Angers
Hôpital Avicenne, Bobigny
Hôpital Saint André, Bordeaux
Hôpital Côte de Nacre, Caen
CHU - Estaing, Clermont-Ferrand
Hôpital Beaujon, Clichy
Centre GF Leclerc, Dijon
CHU - Hôpital François Mitterand, Dijon
Hôpital Edouard Herriot, Lyon
CHU La Timone, Marseille
CHR, Orléans
CHU Cochin, Paris
Hôpital Européen Georges Pompidou, Paris
Hôpital Robert Debré, Reims
CHU, Rouen
Hôpital Rangueil, Toulouse
Hôpital Trousseau, Tours
Institut Gustave Roussy, Villejuif
Federation Francophone de Cancerologie Digestive
OTHER